Skip to main content

Treatment Clinical Trials for Vulvar Cancer

Review the vulvar cancer treatment clinical trials on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-15 of 15

Testing the Treatment of Radiation and Cisplatin Chemotherapy for Patients with Disease which Has Spread and Been Detected in the Sentinel Nodes in Surgically Resected Vulvar Cancer, (GROINSS-V) III Trial
Status: Active
Location: 26 locations
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
Status: Active
Location: 9 locations
Nelfinavir, Cisplatin, and External Beam Radiation Therapy for the Treatment of Locally Advanced Vulvar or Vaginal Cancer That Cannot Be Removed by Surgery
Status: Active
Location: 4 locations
A Study of Lorigerlimab in Participants With Advanced Solid Tumors
Status: Active
Location: 3 locations
HPV L1 Vaccine in Combination with Imiquimod and Metformin for the Treatment of Locally Advanced and Metastatic Cervical, Vaginal and Vulvar Cancers Undergoing Chemoradiation
Status: Active
Location: 2 locations
At-Home Cancer Directed Therapy versus in Clinic for the Treatment of Patients with Advanced Cancer, Cancer CARE Beyond Walls
Status: Active
Location: 2 locations
Reiki Therapy to Improve Symptoms Associated with Brachytherapy in Patients with Gynecological Malignancies, Reiki-Brachy Trial
Status: Active
Location: Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah
Stereotactic Body Radiation Therapy and Atezolizumab in Treating Patients with Recurrent, Persistent, or Metastatic Cervical, Vaginal, or Vulvar Cancer
Status: Active
Location: Ohio State University Comprehensive Cancer Center, Columbus, Ohio
Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1 Nilotinib and Paclitaxel
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
Tivozanib and Atezolizumab for the Treatment of Advanced, Unresectable, or Metastatic Immunologically Cold Tumor Types
Status: Active
Location: UF Health Cancer Institute - Gainesville, Gainesville, Florida
E7 TCR-T Cell Induction Therapy for the Treatment of Locoregionally Advanced HPV-Associated Cancers
Status: Active
Location: Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey
Pomalidomide and Nivolumab for the Treatment of Virus-Associated Malignancies with or without HIV
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
Physical Therapy and Coping Skills Training for Improving Women's Sexual Function after Pelvic Radiation
Status: Active
Location: Duke University Medical Center, Durham, North Carolina
Magnetic Resonance Imaging-Guided Brachytherapy in Treating Patients with Gynecologic Cancers
Status: Active
Location: Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland
Atezolizumab and Bevacizumab in Treating Patients with Rare Solid Tumors
Status: Temporarily Closed to Accrual
Location: UT MD Anderson Cancer Center, Houston, Texas